Reports from China offer evidence of the inconsistency of public authorities when dealing with fake or substandard drugs. Xinhua, the government news agency, reported that Xiong Xuanguo, the Vice President of the Supreme People's Court, had stated that the issue has become a cause of discontent. He said that fake or poorly-manufactured medicines "seriously harm people's health, disturb the healthy development of the pharmaceutical industry in China and severely damage the image of the country internationally." Mr Xiong announced a new interpretation of the country's legal code to allow stiffer punishments.
However, Bian Zhenjia, Deputy Director of the State Food and Drug Administration complained at a news conference that "foreign media" was fabricating stories and foreign drugmakers were ignoring regulations, Reuters reported.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze